Compounds > 2-amino-5-phosphonovalerate
Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Poisoning, Lead

2-amino-5-phosphonovalerate has been researched along with Poisoning, Lead in 2 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpenter, DO1
Matthews, MR1
Parsons, PJ1
Hori, N1
Cory-Slechta, DA1
Garcia-Osuna, M1
Greenamyre, JT1

Other Studies

2 other studies available for 2-amino-5-phosphonovalerate and Poisoning, Lead

ArticleYear
Long-term potentiation in the piriform cortex is blocked by lead.
    Cellular and molecular neurobiology, 1994, Volume: 14, Issue:6

    Topics: 2-Amino-5-phosphonovalerate; Animals; Child; Evoked Potentials; Humans; In Vitro Techniques; Intelli

1994
Lead-induced changes in NMDA receptor complex binding: correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration.
    Behavioural brain research, 1997, Volume: 85, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Animals; Appetitive Behavior; Autoradiography; Brain; Brain Mapping; Di

1997